Morgan Stanley (MS) Stock Forecast & Price Target

$125.17 +0.90 (+0.72%)

As of 10:47 AM Eastern

Morgan Stanley - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 18 Analyst Ratings

Sell
0

Hold
12

Buy
6

Based on 18 Wall Street analysts who have issued ratings for Morgan Stanley in the last 12 months, the stock has a consensus rating of "Hold." Out of the 18 analysts, 12 have given a hold rating, and 6 have given a buy rating for MS.

Consensus Price Target

$132.33
5.73% Upside

According to the 18 analysts' twelve-month price targets for Morgan Stanley, the average price target is $132.33. The highest price target for MS is $156.00, while the lowest price target for MS is $105.00. The average price target represents a forecasted upside of 5.73% from the current price of $125.17.

Get the Latest News and Ratings for MS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Morgan Stanley and its competitors.

MS Analyst Ratings Over Time

Type	Current Forecast 3/25/24 to 3/25/25	1 Month Ago 2/24/24 to 2/23/25	3 Months Ago 12/26/23 to 12/25/24	1 Year Ago 3/26/23 to 3/25/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	6 Buy rating(s)	6 Buy rating(s)	6 Buy rating(s)	6 Buy rating(s)
Hold	12 Hold rating(s)	11 Hold rating(s)	11 Hold rating(s)	12 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$132.33	$131.27	$121.80	$93.90
Forecasted Upside	5.73% Upside	-0.25% Downside	-4.14% Downside	3.05% Upside
Consensus Rating	Hold	Hold	Hold	Hold

Remove Ads

MS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Morgan Stanley Stock vs. The Competition

Type	Morgan Stanley	Finance Companies	S&P 500
Consensus Rating Score	2.33	2.52	2.54
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	4.64% Upside	44.33% Upside	16.92% Upside
News Sentiment Rating	Positive News See Recent MS News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/25/2025	JPMorgan Chase & Co. 3 of 5 stars	Kian Abouhossein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$124.00 ➝ $129.00	+3.57%
3/24/2025	Citigroup 3 of 5 stars	Keith Horowitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$135.00 ➝ $125.00	+0.67%
3/19/2025	The Goldman Sachs Group 3 of 5 stars	Richard Ramsden Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$144.00 ➝ $126.00	+6.24%
3/17/2025	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	H. Engel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
1/21/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brennan Hawken Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$130.00 ➝ $140.00	+2.81%
1/17/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Goldberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$155.00 ➝ $156.00	+13.27%
1/17/2025	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Carrier Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$146.00 ➝ $153.00	+11.43%
1/17/2025	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Glenn Schorr Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$140.00 ➝ $150.00	+10.15%
1/17/2025	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Konrad Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Market Perform ➝ Market Perform	$138.00 ➝ $145.00	+6.78%
11/26/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Martinez Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
Get the Latest News and Ratings for MS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Morgan Stanley and its competitors with MarketBeat's FREE daily newsletter.
11/26/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$128.00 ➝ $131.00	-2.00%
11/15/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underweight ➝ Equal Weight	$107.00 ➝ $142.00	+7.22%
10/17/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Sector Perform ➝ Sector Perform	$108.00 ➝ $122.00	+1.66%
10/17/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$120.00 ➝ $135.00	+12.69%
7/18/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Perform
7/18/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$116.00 ➝ $118.00	+10.42%
7/17/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
4/16/2024	Cfra Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$97.00 ➝ $108.00	+20.82%
11/28/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$80.00	+2.63%
11/20/2023	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Neutral	$85.00	+5.88%
10/23/2023	Odeon Capital Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$79.15	+8.72%
10/20/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underperform ➝ Peer Perform
8/1/2023	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$85.00 ➝ $90.00	-1.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:47 AM ET.

Should I Buy Morgan Stanley Stock? MS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, March 23, 2025. Please send any questions or comments about these Morgan Stanley pros and cons to contact@marketbeat.com.

Morgan Stanley
Bull Case

Here are some ways that investors could benefit from investing in Morgan Stanley:

The current stock price is $120.26, which may present a buying opportunity for investors looking for value in the financial sector.
Morgan Stanley reported a strong quarterly earnings result with earnings per share (EPS) of $2.22, significantly exceeding the consensus estimate of $1.54, indicating robust financial performance.
The company has a market capitalization of $193.96 billion, reflecting its substantial size and stability in the financial services industry.
With a dividend yield of 3.08% and a recent quarterly dividend of $0.925, Morgan Stanley offers attractive income potential for investors seeking regular returns.
The firm has shown a year-over-year revenue growth of 25.9%, suggesting strong operational performance and potential for future growth.

Morgan Stanley
Bear Case

Investors should be bearish about investing in Morgan Stanley for these reasons:

The company has a high debt-to-equity ratio of 3.14, which indicates that it relies heavily on debt financing, potentially increasing financial risk.
Insider selling activity has been noted, with significant shares sold by executives, which may raise concerns about their confidence in the company's future performance.
The stock has experienced volatility, with a beta of 1.35, suggesting that it may be more sensitive to market fluctuations compared to the overall market.
Despite strong earnings, the price-to-earnings (P/E) ratio of 15.15 may indicate that the stock is fairly valued, limiting potential upside for investors looking for undervalued opportunities.
Institutional investors and hedge funds own 84.19% of the stock, which could lead to increased volatility if these large holders decide to sell their positions.

MS Forecast - Frequently Asked Questions

: According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Morgan Stanley is $132.33, with a high forecast of $156.00 and a low forecast of $105.00.
: 18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Morgan Stanley in the last twelve months. There are currently 12 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MS, but not buy additional shares or sell existing shares.
: According to analysts, Morgan Stanley's stock has a predicted upside of 5.73% based on their 12-month stock forecasts.
: Over the previous 90 days, Morgan Stanley's stock had 1 downgrade by analysts.
: Morgan Stanley has been rated by research analysts at Bank of America, Barclays, Citigroup, Erste Group Bank, Evercore ISI, JPMorgan Chase & Co., Keefe, Bruyette & Woods, The Goldman Sachs Group, and UBS Group in the past 90 days.
: Morgan Stanley also publishes sell-side equities research reports and recommendations about other companies, which can be viewed at its brokerage rating page.
: Analysts like Morgan Stanley less than other "finance" companies. The consensus rating for Morgan Stanley is Hold while the average consensus rating for "finance" companies is Moderate Buy. Learn more on how MS compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:MS) was last updated on 3/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Morgan Stanley (MS) Stock Forecast & Price Target